BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
20 hedge funds and large institutions have $12.2M invested in Biolase, Inc. in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
Holders
20
Holders Change
–
Holders Change %
0%
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
4
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.41M |
2 |
ACM
2
Archon Capital Management
Seattle,
Washington
|
$2.29M |
3 |
3
BlackRock
New York
|
$440K |
Top Sellers
1 |
OIM
1
Oracle Investment Management
Greenwich,
Connecticut
|
$7.61M |
2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
3 |
3
UBS Group
Zurich,
Switzerland
|
$14K |
4 |
4
Morgan Stanley
New York
|
$14K |